Xanthine oxidase inhibitory activity of some indian medical plantsUMAMAHESWARI, Muthuswamy; ASOKKUMAR, Kuppusamy; SOMASUNDARAM, Arumugam et al.Journal of ethnopharmacology. 2007, Vol 109, Num 3, pp 547-551, issn 0378-8741, 5 p.Article

No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approachPFISTER, R; BARNES, D; LUBEN, R et al.Diabetologia (Berlin). 2011, Vol 54, Num 10, pp 2561-2569, issn 0012-186X, 9 p.Article

Long-term adherence to the Mediterranean diet reduces the prevalence of hyperuricaemia in elderly individuals, without known cardiovascular disease: The Ikaria studyCHRYSOHOOU, Christina; SKOUMAS, John; MAMATAS, Spyros et al.Maturitas (Amsterdam). 2011, Vol 70, Num 1, pp 58-64, issn 0378-5122, 7 p.Article

Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in goutKRISHNAN, Eswar.Rheumatology (Oxford. Print). 2010, Vol 49, Num 7, pp 1229-1238, issn 1462-0324, 10 p.Article

Dietary purines in vegetarian meat analoguesHAVLIK, Jaroslav; PLACHY, Vladimir; FERNANDEZ, Javier et al.Journal of the science of food and agriculture. 2010, Vol 90, Num 14, pp 2352-2357, issn 0022-5142, 6 p.Article

Risk factors for acute kidney injury by non-steroidal anti-inflammatory drugs in patients with hyperuricaemiaKI WON MOON; KIM, Joonwan; JIN HYUN KIM et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 12, pp 2278-2282, issn 1462-0324, 5 p.Article

Hyperuricaemia is an independent factor for the metabolic syndrome in a sub-Saharan African population : A factor analysisREIMANN, Manja; SCHUTTE, Aletta E; MALAN, Leoné et al.Atherosclerosis. 2008, Vol 197, Num 2, pp 638-645, issn 0021-9150, 8 p.Article

Lowering serum urate does not improve endothelial function in patients with type 2 diabetesWARING, W. S; MCKNIGHT, J. A; WEBB, D. J et al.Diabetologia (Berlin). 2007, Vol 50, Num 12, pp 2572-2579, issn 0012-186X, 8 p.Article

Near-iron deficiency-induced remission of gouty arthritisFACCHINI, Francesco S.Rheumatology (Oxford. Print). 2003, Vol 42, Num 12, pp 1550-1555, issn 1462-0324, 6 p.Article

The modern management of goutRIDER, Tom G; JORDAN, Kelsey M.Rheumatology (Oxford. Print). 2010, Vol 49, Num 1, pp 5-14, issn 1462-0324, 10 p.Article

The polymorphism -863C/A in tumour necrosis factor-α gene contributes an independent association to goutCHANG, S.-J; TSAI, P.-C; CHEN, C.-J et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 11, pp 1662-1666, issn 1462-0324, 5 p.Article

Overview of hyperuricaemia and gout : Biochemical and clinical relevance of hyperuricaemiaMASSEOUD, D; ROTT, K; LIU-BRYAN, R et al.Current pharmaceutical design. 2005, Vol 11, Num 32, pp 4117-4124, issn 1381-6128, 8 p.Article

Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological dataFILIPPATOS, Gerasimos S; AHMED, Mustafa I; GLADDEN, James D et al.European heart journal. 2011, Vol 32, Num 6, pp 712-720, issn 0195-668X, 9 p.Article

Rasburicasa versus alopurinol como tratamiento de la hiperuricemia en el síndrome de lisis tumoral = Rasburicase versus allopurinol in the treatment of hyperuricaemia in tumour lysis syndromeSANCHEZ TATAY, V; LOPEZ CASTILLA, J. D; CARMONA PONCE, J. M et al.Anales de pediatria (2003. Ed. impresa). 2010, Vol 72, Num 2, pp 103-110, issn 1695-4033, 8 p.Article

Crystal ball gazing : new therapeutic targets for hyperuricaemia and goutDALBETH, N; MERRIMAN, T.Rheumatology (Oxford. Print). 2009, Vol 48, Num 3, pp 222-226, issn 1462-0324, 5 p.Article

Febuxostat in the treatment of gout : 5-yr findings of the FOCUS efficacy and safety studySCHUMACHER, H. R; BECKER, M. A; LLOYD, E et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 2, pp 188-194, issn 1462-0324, 7 p.Article

New insights into the epidemiology of goutDOHERTY, Michael.Rheumatology (Oxford. Print). 2009, Vol 48, issn 1462-0324, ii2-ii8, SUP2Article

Intermittent elevation of serum urate and 24-hour urinary uric acid excretionYU, K.-H; LUO, S.-F; TSAI, W.-P et al.Rheumatology (Oxford. Print). 2004, Vol 43, Num 12, pp 1541-1545, issn 1462-0324, 5 p.Article

Association between endothelial dysfunction and hyperuricaemiaHO, Wan-Jing; TSAI, Wen-Pin; YU, Kuang-Hui et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 10, pp 1929-1934, issn 1462-0324, 6 p.Article

Gout: an independent risk factor for all-cause and cardiovascular mortalityKUO, Chang-Fu; SEE, Lai-Chu; LUO, Shue-Fen et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 1, pp 141-146, issn 1462-0324, 6 p.Article

Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional studyKUO, Chang-Fu; YU, Kuang-Hui; TSENG, Wen-Yi et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 6, pp 1189-1196, issn 1462-0324, 8 p.Article

Uric acid and evolutionALVAREZ-LARIO, Bonifacio; MACARRON-VICENTE, Jesús.Rheumatology (Oxford. Print). 2010, Vol 49, Num 11, pp 2010-2015, issn 1462-0324, 6 p.Article

Allopurinol and mortality in hyperuricaemic patientsLUK, Andrew J; LEVIN, Gregory P; MOORE, Elya E et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 7, pp 804-806, issn 1462-0324, 3 p.Article

Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patientsANNEMANS, L; MOEREMANS, K; LAMOTTE, M et al.Supportive care in cancer. 2003, Vol 11, Num 4, pp 249-257, issn 0941-4355, 9 p.Article

The elevated prevalence of apolipoprotein E2 in patients with gout is associated with reduced renal excretion of uratesCARDONA, F; TINAHONES, F. J; COLLANTES, E et al.Rheumatology (Oxford. Print). 2003, Vol 42, Num 3, pp 468-472, issn 1462-0324, 5 p.Article